The Outlook for COVID-19 Treatments
Bloomberg Businessweek

The Outlook for COVID-19 Treatments

Jun 19, 2020
40:09
-(0)

About this episode

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, discusses the latest on Dexamethasone as a treatment for COVID-19 and New York City’s phase two of reopening. Bloomberg Businessweek Editor Joel Weber and Businessweek Editor Silvia Killingsworth walk through stories from the food section in this week's magazine. We get Businessweek Economics with Bloomberg News Economics Reporter Steve Matthews. He talks about his interview with Atlanta Fed President Raphael Bostic. Jason Kelly, CEO at Ginkgo Bioworks, walks through enabling large-scale COVID-19 testing. And we Drive to the Close with Kevin Miller, CIO of E-Valuator Funds. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. See omnystudio.com/listener for privacy information.

Comments

Rate this episode

Episode Details

Author
Bloomberg
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy